Premium
Advice regarding COVID‐19 and use of immunomodulators, in patients with severe dermatological diseases
Author(s) -
Rademaker Marius,
Baker Christopher,
Foley Peter,
Sullivan John,
Wang Charlie
Publication year - 2020
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13295
Subject(s) - medicine , infliximab , acitretin , apremilast , adalimumab , azathioprine , dermatology , ustekinumab , ixekizumab , etanercept , secukinumab , tocilizumab , immunology , psoriasis , psoriatic arthritis , disease , rheumatoid arthritis , tumor necrosis factor alpha
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom